Begin main content

Duration of Dosage Effect for Methylphenidate SR and Dextroamphetamine SR for Patients with Attention Deficit Hyperactivity Disorder

Last updated: September 2, 2015
Project Number: RB0904-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical evidence for the duration of dosage effect for methylphenidate SR and dextroamphetamine SR for patients with attention deficit hyperactivity disorder?

Key Message

One systematic review, two randomized controlled trials, and two non-randomized studies were identified regarding the duration of dosage effect for methylphenidate SR for patients with attention deficit hyperactivity disorder.